#2981 ·
redpuma10 said:Hello.
Could someone please help me interpret these tissue typing results? They were ordered due to polyarthritis, though the specific diagnosis—whether unspecified or rheumatoid arthritis—is still being determined. Thanks in advance.
HLA-A 02 11
HLA-B35.
HLA-C* NT NT
HLA-DRB1*0101. Just a marker. A genetic fingerprint that points toward certain risks. It’s one piece of a much larger puzzle.
HLA-DQB1* NT NT
To whom it may concern,
The lab results indicate a genetic predisposition for rheumatoid arthritis. Specifically, you carry the HLA-DRB1*01 allele. In the context of the American population, this is the most frequent allele found among patients diagnosed with RA. There is a caveat, however: the typing wasn't performed with enough granular detail, as the actual high-risk allele is specifically hla-drb1*0101. If clinical symptoms are present—especially if accompanied by a positive rheumatoid factor—the probability of developing rheumatoid arthritis is significant.
Looking at your lab results, there's one specific marker worth noting: HLA-B35. It’s sometimes linked to a higher frequency of spondylarthritis—the kind that affects the spine—though the connection isn't particularly conclusive.
The other HLA alleles in your results aren't tied to any specific autoimmune condition. It’s a bit like having a slight predisposition to something—most HLA types carry some marginal increase in risk for various issues, but they don't point to one definitive diagnosis.
brightranger49 said:Hello.
My results finally arrived.imageCases where levels are elevated:
AST levels came back at 41 U/L. The standard reference range is 8 to 30. Slightly elevated.
ALT levels: 50 U/L (Reference range: 10 - 36).
I’ve been on Salazopyrin (2x2) for just over a month now, following my rheumatologist's advice. They're looking into suspected spondyloarthropathy. The inflammation hits my knuckles hardest, followed by my shoulders and a few other spots. I'm 39, and this has been dragging on for a couple of years; until now, I hadn't started any formal treatment. Other than that, I'm doing alright, though I have been postmenopausal since my mid-30s and am currently on hormone replacement therapy (Angeliq).
My rheumatologist ordered some liver function tests to monitor how this new medication is hitting my system. The results came back slightly elevated. My GP—who’s just filling in right now—is essentially stumped; they honestly can't decide whether I should stay the course or pull the plug on the treatment entirely. They asked if I was dealing with any new symptoms like fevers or headaches. I mentioned the migraines, though those have been part of the furniture for a long time. I tried reaching out to my specialist, but they aren't back in the office until mid-month.
I'm at a crossroads. Should I stick with the Salazopyrin or pull the plug on this therapy?
Thanks.
To whom it may concern,
Generally speaking, when it comes to taking Salazopyrin, the rule of thumb regarding AST or ALT levels is straightforward. If your numbers are sitting at or below twice the upper limit of normal, there’s no need to touch the dosage. If they climb between two and three times that limit, you might need to consider scaling back the dose or potentially stopping altogether. However, once those values exceed three times the upper limit, the medication should be discontinued immediately.
When you first start this medication, it’s wise to have your liver enzyme levels checked every two to four weeks. It's just standard procedure.
Your labs show that your AST and ALT levels are sitting at 1.4 times the upper limit of normal. Given that, you could probably stick with the current dose of Salazopyrin, provided we monitor those numbers every two weeks.
That said, this is just general guidance. I can't take responsibility for it through a screen since I don't have the full picture of your medical history.
[/IMG]